SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-467086
Filing Date
2016-02-17
Accepted
2016-02-17 16:03:32
Documents
10
Period of Report
2016-02-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d87136d8k.htm 8-K 15373
2 EX-99.1 d87136dex991.htm EX-99.1 20819
3 EX-99.2 d87136dex992.htm EX-99.2 6222
4 GRAPHIC g87136ex99_2s1g1.jpg GRAPHIC 234769
5 GRAPHIC g87136ex99_2s2g1.jpg GRAPHIC 519498
6 GRAPHIC g87136ex99_2s3g1.jpg GRAPHIC 194679
7 GRAPHIC g87136ex99_2s4g1.jpg GRAPHIC 247040
8 GRAPHIC g87136ex99_2s5g1.jpg GRAPHIC 284786
9 GRAPHIC g87136ex99_2s6g1.jpg GRAPHIC 265070
10 GRAPHIC g87136img.jpg GRAPHIC 5288
  Complete submission text file 0001193125-16-467086.txt   2456083
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 161433190
SIC: 2836 Biological Products, (No Diagnostic Substances)